摘要:
This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C. difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO: 2 and SEQ ID NO: 4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C. difficile toxin A and/or toxin B.
摘要:
This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C.difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO:2 and SEQ ID NO:4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C.difficile toxin A and/or toxin B.
摘要翻译:本发明提供了C-TAB.G5和C-TAB.G5.1分离的多肽,其包含如SEQ ID NO:2和SEQ ID NO:2的氨基酸序列中所示的C.difficile毒素A和毒素B的受体结合结构域 NO:4。 C-TAB.G5和C-TAB.G5.1分离的多肽可用于中和C.difficile毒素A和/或毒素B的毒性作用。
摘要:
This present invention provides C-TAB.G5 and C-TAB.G5.1 isolated polypeptides comprising the receptor binding domains of C.difficile toxin A and toxin B as set forth in the amino acid sequences of SEQ ID NO:2 and SEQ ID NO:4. The C-TAB.G5 and C-TAB.G5.1 isolated polypeptides may be used to neutralize toxic effects of C.difficile toxin A and/or toxin B.